Explore the complete record of transactions filed by Fernandez Henry A, Chairman & CEO. Director active across 2 companies, notably Royalty Pharma plc. Aggregated, 14 disclosures have been recorded. Total volume traded: €1.1m. The latest transaction was disclosed on 30 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Henry A. Fernandez is a Board Member and Chairman and CEO at Royalty Pharma plc and MSCI Inc. He plays a key role in governance and strategic direction of these companies. His experience is valuable in guiding initiatives and ensuring growth.